Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Nature Biomed Engin ×

Nature Biomed Engin

This institution is selected. Its supporting articles are shown below.

Nature Biomed Engin1

Articles mentioning Nature Biomed Engin

1 articles · page 1 of 1

OC.55 Reconnoiter-1: a phase 2, prospective, blinded, randomized, parallel-group and crossover clinical trial evaluating AISA-021, a novel ccb, in subjects with Raynaud’s phenomenon (SSc-RP

jsrd · abstract · 2026-06-05 · 1 matching annotations

87.7%

Nature Biomed Engin SSc-RP AISA-021 SSc SLE-RP cilnidipine RA-RP ILD

…ay reduce ILD and fibrosis (Jang.; Resp Med 237(2025)), (Zheng; Nature Biomed Engin (2025). We studied AISA-021(cilnidipine), a dual N + L-type CCB…

Browse institutions

Nature Biomed Engin

Articles mentioning Nature Biomed Engin

OC.55 Reconnoiter-1: a phase 2, prospective, blinded, randomized, parallel-group and crossover clinical trial evaluating AISA-021, a novel ccb, in subjects with Raynaud’s phenomenon (SSc-RP